Seoul St. Mary's Hospital Blood Hospital Lymphoma Center achieves its first 4,000 cases in Korea through multidisciplinary cooperation
Nov 06, 2025
Seoul St. Mary's Hospital, which established Korea's first blood hospital, held a 4,000-year ceremony in the seminar room on the basement floor of the hospital on the 5th.
Several medical and medical staff, faculty, and senior professors who first established a cooperative system gathered together to look back on the history of the past 17 years. Since there was no health insurance treatment for multidisciplinary cooperation in 2009, multidisciplinary face-to-face treatment, which began with the opening of a new hospital at Seoul St. Mary's Hospital, has been a place to celebrate and encourage the solid establishment of a patient-centered medical service.
The number of multi-disciplinary cooperation, which was held once a week, reached 4,187 as of November, the highest in Korea.
Multidisciplinary cooperation is a system in which several medical doctors gather to discuss patient treatments. With the recent development of diagnostic techniques and the entry of an aging era, the incidence of lymphoma, a blood cancer, is also increasing, and the importance of multidisciplinary cooperation through interviews is increasing. With the development of medical knowledge and medical technology, each discipline has been subdivided and specialized, but in a situation where understanding and communication are difficult, cooperative care voluntarily led by hospitals provides accurate and rapid diagnosis and optimal treatment opportunities for patients and improves reliability and satisfaction.
The lymphoma center is led by hematology, and specialized medical staff related to the diagnosis and treatment of cancer patients such as radiology oncology, radiology, pathology, nuclear medicine, ophthalmology, gastroenterology, and respiratory medicine explain the diagnosis and treatment plan to patients in one clinic. Caregivers who have questions and anxiety about the disease and treatment process will also attend multidisciplinary face-to-face integrated care.
Professional medical staff from each clinical department directly explain details from diagnosis and treatment processes, treatment results and treatment plans, and provide psychological stability through sufficient dialogue with patients. In order to increase the cure rate of lymphoma patients through face-to-face integrated treatment and prevent recurrence, it is focusing on actively utilizing various treatments and developing new treatment strategies.
Multidisciplinary collaboration at the Lymphoma Center takes place every Wednesday from 10 a.m. to 12 p.m., and usually takes about 20 minutes per patient. The multidisciplinary cooperation team includes △blood internal medicine (Professor Cho Seok-gu and Min Ki-jun) △ gastrointestinal medicine (Professor Kang Dong-hoon) △ respiratory medicine (Professor Lee Jin-guk) △ ophthalmology (Professor Yang Seok-woo and Park Jung-yeol) △ radiological oncology (Professor Choi Byung-ok, Choi Kyu-hye) △ pathology (Professor Park Kyung-shin, Kim Soo-yeon) △ radiology (Professor Choi Joon-il), △ nuclear medicine (Professor Oh Joo-hyun), △ professional nurse (Lee.
Lee Ji-yeol, director of Seoul St. Mary's Hospital, said "I think the lymphoma center, which has been carrying out a difficult journey by gathering several experts in one place to conduct multi-disciplinary face-to-face treatment, is a model case of the hospital."I hope that with this opportunity, blood hospitals can leap from No. 1 in Korea to No. 1 in the world and save more patients' lives," he said.
Professor Min Ki-jun, head of the Lymphoma Center, said, `The multidisciplinary cooperation is focused on patients with high satisfaction of patients and guardians as experts in each field consult to determine the treatment direction and ask questions about patients.'
Several medical and medical staff, faculty, and senior professors who first established a cooperative system gathered together to look back on the history of the past 17 years. Since there was no health insurance treatment for multidisciplinary cooperation in 2009, multidisciplinary face-to-face treatment, which began with the opening of a new hospital at Seoul St. Mary's Hospital, has been a place to celebrate and encourage the solid establishment of a patient-centered medical service.
The number of multi-disciplinary cooperation, which was held once a week, reached 4,187 as of November, the highest in Korea.
Multidisciplinary cooperation is a system in which several medical doctors gather to discuss patient treatments. With the recent development of diagnostic techniques and the entry of an aging era, the incidence of lymphoma, a blood cancer, is also increasing, and the importance of multidisciplinary cooperation through interviews is increasing. With the development of medical knowledge and medical technology, each discipline has been subdivided and specialized, but in a situation where understanding and communication are difficult, cooperative care voluntarily led by hospitals provides accurate and rapid diagnosis and optimal treatment opportunities for patients and improves reliability and satisfaction.
The lymphoma center is led by hematology, and specialized medical staff related to the diagnosis and treatment of cancer patients such as radiology oncology, radiology, pathology, nuclear medicine, ophthalmology, gastroenterology, and respiratory medicine explain the diagnosis and treatment plan to patients in one clinic. Caregivers who have questions and anxiety about the disease and treatment process will also attend multidisciplinary face-to-face integrated care.
Professional medical staff from each clinical department directly explain details from diagnosis and treatment processes, treatment results and treatment plans, and provide psychological stability through sufficient dialogue with patients. In order to increase the cure rate of lymphoma patients through face-to-face integrated treatment and prevent recurrence, it is focusing on actively utilizing various treatments and developing new treatment strategies.
Multidisciplinary collaboration at the Lymphoma Center takes place every Wednesday from 10 a.m. to 12 p.m., and usually takes about 20 minutes per patient. The multidisciplinary cooperation team includes △blood internal medicine (Professor Cho Seok-gu and Min Ki-jun) △ gastrointestinal medicine (Professor Kang Dong-hoon) △ respiratory medicine (Professor Lee Jin-guk) △ ophthalmology (Professor Yang Seok-woo and Park Jung-yeol) △ radiological oncology (Professor Choi Byung-ok, Choi Kyu-hye) △ pathology (Professor Park Kyung-shin, Kim Soo-yeon) △ radiology (Professor Choi Joon-il), △ nuclear medicine (Professor Oh Joo-hyun), △ professional nurse (Lee.
Lee Ji-yeol, director of Seoul St. Mary's Hospital, said "I think the lymphoma center, which has been carrying out a difficult journey by gathering several experts in one place to conduct multi-disciplinary face-to-face treatment, is a model case of the hospital."I hope that with this opportunity, blood hospitals can leap from No. 1 in Korea to No. 1 in the world and save more patients' lives," he said.
Professor Min Ki-jun, head of the Lymphoma Center, said, `The multidisciplinary cooperation is focused on patients with high satisfaction of patients and guardians as experts in each field consult to determine the treatment direction and ask questions about patients.'
|
This article was translated by Naver AI translator.
